 <h1>Metronidazole topical Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>More frequently reported side effects include:</b> cervical candidiasis and vaginitis.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to metronidazole topical: topical cream, topical gel/jelly, topical lotion</i></p><p>Other dosage forms:</p><ul><li>vaginal gel/jelly</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, metronidazole topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of metronidazole topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Dry skin</li>
<li>redness or other signs of skin irritation not present before use of this medicine</li>
<li> stinging or burning of the skin</li>
<li>watering of eyes </li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Metallic taste in the mouth</li>
<li>nausea </li>
<li>tingling or numbness of arms, legs, hands, or feet </li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to metronidazole topical: topical cream, topical gel, topical kit, topical lotion, vaginal gel with applicator</i></p><h3>Local</h3><p><b>Very common</b> (10% or more): Dryness (up to 28.5%), scaling (up to 24.6%), itching (up to 16.3%), pruritus (up to 15.8%), stinging (up to 11%), stinging/burning (up to 10.3%)</p>
<p><b>Common</b> (1% to 10%): Burning, local allergic reaction</p>
<p><b>Frequency not reported</b>: Condition aggravated (rosacea or acne), transient redness, irritation</p>
<p><b>Postmarketing reports</b>: Application site reaction, local irritation<sup>[Ref]</sup></p><p>Local cutaneous signs/symptoms of irritation that were worse than baseline included dryness (25.4% [mild: 17.1%; moderate: 7.7%; severe: 0.6%]), scaling (24.6% [mild: 16.2%; moderate: 7.9%; severe: 0.6%]), pruritus (15.8% [mild: 9.7%; moderate: 5%; severe: 1.1%]), and stinging/burning (10.3% [mild: 7.2%; moderate: 1.3%; severe: 1.8%]).<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal discharge (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Candida cervicitis/vaginitis, yeast infection, dysmenorrhea, metrorrhagia, vulvovaginal candidiasis, vulvovaginal pruritus, urinary tract infection (UTI), vaginal itching/irritation/burning/numbness, vulva/vaginal irritative symptoms, pelvic discomfort</p>
<p><b>Uncommon</b> (0.1% to 1%): Vaginal mycosis, urine discoloration, UTI symptoms, vulva edema, menstrual discomfort/irregularities, vaginal spotting/bleeding</p>
<p><b>Frequency not reported</b>: Breast enlargement, dysuria, female lactation, labial edema, menorrhagia, salpingitis, urinary frequency, vulvovaginal disorder, vulvovaginal discomfort, itching (vaginal and perianal), vulvar burning, vulvar lesions, uterine/menstrual/vaginal cramping, darkened urine</p>
<p><b>Postmarketing reports</b>: Leukorrhea, vaginitis, vulvar disorder, genital pruritus</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Yeast infection, darkened urine, vaginal discharge, vaginal itching, overgrowth of Candida in vagina, dyspareunia, proctitis, dysuria, cystitis, polyuria, incontinence, sense of pelvic pressure, vulva/vaginal irritative symptoms, itching (vaginal and perianal), vulvar burning, vulvar lesions, vaginal burning, pelvic discomfort, uterine/menstrual/vaginal cramping<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fungal infection (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Infection, breast pain, unspecified cramping, abscess, accidental injury</p>
<p><b>Uncommon</b> (0.1% to 1%): Fatigue</p>
<p><b>Frequency not reported</b>: Mucous membrane disorder, pain, thirst, surgical/medical procedure</p>
<p><b>Postmarketing reports</b>: Swelling face, facial edema, treatment failure (worsening of rosacea)</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Fatigue, weakness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Influenza (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Pharyngitis, bronchitis, nasopharyngitis, sinusitis, rhinitis, upper respiratory tract infection, nasal congestion</p>
<p><b>Frequency not reported</b>: Asthma<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, diarrhea/loose stools, gastritis, tooth disorder, gastrointestinal discomfort, abdominal cramps, vomiting, unpleasant taste/unusual feeling on tongue</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth, abdominal bloating/noises</p>
<p><b>Frequency not reported</b>: Dyspepsia, flatulence, gingivitis, abdominal cramping, abdominal bloating/gas</p>
<p><b>Postmarketing reports</b>: Abdominal pain, diarrhea, nausea</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Nausea, unpleasant taste/feeling on tongue, diarrhea, constipation, abdominal cramping, abdominal discomfort, vomiting, epigastric distress, "furry" tongue, glossitis, stomatitis, pancreatitis, gastrointestinal discomfort, gastrointestinal disturbance<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, unpleasant taste, hypertonia</p>
<p><b>Uncommon</b> (0.1% to 1%): Metallic taste, dysgeusia/unusual taste, paresthesia, hypoesthesia</p>
<p><b>Frequency not reported</b>: Ataxia, drowsiness</p>
<p><b>Postmarketing reports</b>: Peripheral neuropathy, taste perversion, dizziness, headache, paresthesia, metallic taste, tingling/numbness of extremities</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Unpleasant taste, dizziness, headache, convulsive seizures, encephalopathy, aseptic meningitis, peripheral neuropathy (characterized mainly by numbness/paresthesia of an extremity), syncope, vertigo, incoordination, ataxia, confusion, dysarthria, unpleasant metallic taste, taste of alcoholic beverages modified<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Flattening of T-wave in ECG tracings<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, contact dermatitis, dry skin, skin discomfort (burning, pain of skin/stinging), erythema/transient skin erythema, worsening of rosacea, skin irritation, psoriasis, seborrhea, skin infection, sunburn, urticaria</p>
<p><b>Frequency not reported</b>: Acne, sweating, generalized itching/rash, severe flare of comedonal acne, rosacea aggravated</p>
<p><b>Postmarketing reports</b>: Hyperpigmentation, pigmentation disorder, hypertrichosis, rash, urticaria, contact dermatitis, skin exfoliation, erythema, pruritus, burning, dryness, tightness, discomfort, rash, zoster lesion, pustules on the nose, vesicular bullous eruption</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Urticaria, angioedema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Frequency not reported</b>: Anorexia, hypomagnesemia</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Decreased appetite, anorexia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Bursitis, myalgia, osteoporosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Back pain, cramp<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Increased/decreased WBC counts</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Reversible neutropenia, reversible thrombocytopenia</p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis</p>
<p><b>Frequency not reported</b>: Eye irritation (watering/tearing)</p>
<p><b>Postmarketing reports</b>: Eyelid edema, watery eyes</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Optic neuropathy<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Skin carcinoma</p>
<p><b>Uncommon</b> (0.1% to 1%): Basal cell carcinoma</p>
<p><b>Frequency not reported</b>: Skin cancer<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hypothyroidism</p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reaction</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Allergic reaction, hypersensitivity reactions (including urticaria, erythematous rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, flushing, nasal congestion, dryness of mouth/vagina/vulva, fever, pruritus, fleeting joint pains), anaphylaxis</p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Depression, difficulty sleeping, irritability</p>
<p><b>Frequency not reported</b>: Insomnia</p>
<p></p>
<p>Oral or parenteral formulations:</p>
<p>-Frequency not reported: Trouble sleeping, irritability, depression, insomnia, decreased libido<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Abnormal liver function test<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Pyelonephritis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. MetroNIDAZOLE Topical (metroNIDAZOLE topical)." G &amp; W Laboratories Inc, South Plainfield, NJ. </p><p id="ref_2">2. "Product Information. Vandazole (metroNIDAZOLE topical)." Upsher-Smith Laboratories Inc, Minneapolis, MN. </p><p id="ref_3">3. "Product Information. MetroLotion (metroNIDAZOLE topical)." Galderma Laboratories Inc, Cranbury, NJ. </p><p id="ref_4">4. "Product Information. Metrogel (metronidazole)." Galderma Laboratories Inc, Fort Worth, TX. </p><p id="ref_5">5. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_6">6. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_7">7. "Product Information. Rosadan (metroNIDAZOLE topical)." Medimetriks Pharmaceuticals Inc, Fairfield, NJ. </p><p id="ref_8">8. "Product Information. MetroNIDAZOLE Vaginal (metroNIDAZOLE topical)." Oceanside Pharmaceuticals, Bridgewater, NJ. </p><p id="ref_9">9. "Product Information. Noritate (metroNIDAZOLE topical)." sanofi-aventis, Bridgewater, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about metronidazole topical</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>269 Reviews</li>
<li>Drug class: topical anti-rosacea agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Metronidazole vaginal</li>
<li>Metronidazole Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Metronidazole Vaginal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>MetroGel, MetroGel-Vaginal, MetroCream, Nuvessa, ... +6 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +5 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Rosacea</li>
<li>Bacterial Vaginitis</li>
<li>Perioral Dermatitis</li>
<li>Balanoposthitis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to metronidazole topical: topical cream, topical gel, topical kit, topical lotion, vaginal gel with applicator</i></p><h3>Local</h3><p><b>Very common</b> (10% or more): Dryness (up to 28.5%), scaling (up to 24.6%), itching (up to 16.3%), pruritus (up to 15.8%), stinging (up to 11%), stinging/burning (up to 10.3%)</p><p><b>Common</b> (1% to 10%): Burning, local allergic reaction</p><p><b>Frequency not reported</b>: Condition aggravated (rosacea or acne), transient redness, irritation</p><p><b>Postmarketing reports</b>: Application site reaction, local irritation<sup>[Ref]</sup></p><p>Local cutaneous signs/symptoms of irritation that were worse than baseline included dryness (25.4% [mild: 17.1%; moderate: 7.7%; severe: 0.6%]), scaling (24.6% [mild: 16.2%; moderate: 7.9%; severe: 0.6%]), pruritus (15.8% [mild: 9.7%; moderate: 5%; severe: 1.1%]), and stinging/burning (10.3% [mild: 7.2%; moderate: 1.3%; severe: 1.8%]).<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal discharge (up to 12%)</p><p><b>Common</b> (1% to 10%): Candida cervicitis/vaginitis, yeast infection, dysmenorrhea, metrorrhagia, vulvovaginal candidiasis, vulvovaginal pruritus, urinary tract infection (UTI), vaginal itching/irritation/burning/numbness, vulva/vaginal irritative symptoms, pelvic discomfort</p><p><b>Uncommon</b> (0.1% to 1%): Vaginal mycosis, urine discoloration, UTI symptoms, vulva edema, menstrual discomfort/irregularities, vaginal spotting/bleeding</p><p><b>Frequency not reported</b>: Breast enlargement, dysuria, female lactation, labial edema, menorrhagia, salpingitis, urinary frequency, vulvovaginal disorder, vulvovaginal discomfort, itching (vaginal and perianal), vulvar burning, vulvar lesions, uterine/menstrual/vaginal cramping, darkened urine</p><p><b>Postmarketing reports</b>: Leukorrhea, vaginitis, vulvar disorder, genital pruritus</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Yeast infection, darkened urine, vaginal discharge, vaginal itching, overgrowth of Candida in vagina, dyspareunia, proctitis, dysuria, cystitis, polyuria, incontinence, sense of pelvic pressure, vulva/vaginal irritative symptoms, itching (vaginal and perianal), vulvar burning, vulvar lesions, vaginal burning, pelvic discomfort, uterine/menstrual/vaginal cramping<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fungal infection (up to 12%)</p><p><b>Common</b> (1% to 10%): Infection, breast pain, unspecified cramping, abscess, accidental injury</p><p><b>Uncommon</b> (0.1% to 1%): Fatigue</p><p><b>Frequency not reported</b>: Mucous membrane disorder, pain, thirst, surgical/medical procedure</p><p><b>Postmarketing reports</b>: Swelling face, facial edema, treatment failure (worsening of rosacea)</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Fatigue, weakness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Influenza (up to 11%)</p><p><b>Common</b> (1% to 10%): Pharyngitis, bronchitis, nasopharyngitis, sinusitis, rhinitis, upper respiratory tract infection, nasal congestion</p><p><b>Frequency not reported</b>: Asthma<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, diarrhea/loose stools, gastritis, tooth disorder, gastrointestinal discomfort, abdominal cramps, vomiting, unpleasant taste/unusual feeling on tongue</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth, abdominal bloating/noises</p><p><b>Frequency not reported</b>: Dyspepsia, flatulence, gingivitis, abdominal cramping, abdominal bloating/gas</p><p><b>Postmarketing reports</b>: Abdominal pain, diarrhea, nausea</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Nausea, unpleasant taste/feeling on tongue, diarrhea, constipation, abdominal cramping, abdominal discomfort, vomiting, epigastric distress, "furry" tongue, glossitis, stomatitis, pancreatitis, gastrointestinal discomfort, gastrointestinal disturbance<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, unpleasant taste, hypertonia</p><p><b>Uncommon</b> (0.1% to 1%): Metallic taste, dysgeusia/unusual taste, paresthesia, hypoesthesia</p><p><b>Frequency not reported</b>: Ataxia, drowsiness</p><p><b>Postmarketing reports</b>: Peripheral neuropathy, taste perversion, dizziness, headache, paresthesia, metallic taste, tingling/numbness of extremities</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Unpleasant taste, dizziness, headache, convulsive seizures, encephalopathy, aseptic meningitis, peripheral neuropathy (characterized mainly by numbness/paresthesia of an extremity), syncope, vertigo, incoordination, ataxia, confusion, dysarthria, unpleasant metallic taste, taste of alcoholic beverages modified<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Flattening of T-wave in ECG tracings<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, contact dermatitis, dry skin, skin discomfort (burning, pain of skin/stinging), erythema/transient skin erythema, worsening of rosacea, skin irritation, psoriasis, seborrhea, skin infection, sunburn, urticaria</p><p><b>Frequency not reported</b>: Acne, sweating, generalized itching/rash, severe flare of comedonal acne, rosacea aggravated</p><p><b>Postmarketing reports</b>: Hyperpigmentation, pigmentation disorder, hypertrichosis, rash, urticaria, contact dermatitis, skin exfoliation, erythema, pruritus, burning, dryness, tightness, discomfort, rash, zoster lesion, pustules on the nose, vesicular bullous eruption</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Urticaria, angioedema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Frequency not reported</b>: Anorexia, hypomagnesemia</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Decreased appetite, anorexia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Bursitis, myalgia, osteoporosis</p><p><b>Uncommon</b> (0.1% to 1%): Back pain, cramp<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Increased/decreased WBC counts</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Reversible neutropenia, reversible thrombocytopenia</p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis</p><p><b>Frequency not reported</b>: Eye irritation (watering/tearing)</p><p><b>Postmarketing reports</b>: Eyelid edema, watery eyes</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Optic neuropathy<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Skin carcinoma</p><p><b>Uncommon</b> (0.1% to 1%): Basal cell carcinoma</p><p><b>Frequency not reported</b>: Skin cancer<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hypothyroidism</p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reaction</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Allergic reaction, hypersensitivity reactions (including urticaria, erythematous rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, flushing, nasal congestion, dryness of mouth/vagina/vulva, fever, pruritus, fleeting joint pains), anaphylaxis</p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Depression, difficulty sleeping, irritability</p><p><b>Frequency not reported</b>: Insomnia</p><p></p><p>Oral or parenteral formulations:</p><p>-Frequency not reported: Trouble sleeping, irritability, depression, insomnia, decreased libido<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Abnormal liver function test<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Pyelonephritis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. MetroNIDAZOLE Topical (metroNIDAZOLE topical)." G &amp; W Laboratories Inc, South Plainfield, NJ. </p><p id="ref_2">2. "Product Information. Vandazole (metroNIDAZOLE topical)." Upsher-Smith Laboratories Inc, Minneapolis, MN. </p><p id="ref_3">3. "Product Information. MetroLotion (metroNIDAZOLE topical)." Galderma Laboratories Inc, Cranbury, NJ. </p><p id="ref_4">4. "Product Information. Metrogel (metronidazole)." Galderma Laboratories Inc, Fort Worth, TX. </p><p id="ref_5">5. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_6">6. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_7">7. "Product Information. Rosadan (metroNIDAZOLE topical)." Medimetriks Pharmaceuticals Inc, Fairfield, NJ. </p><p id="ref_8">8. "Product Information. MetroNIDAZOLE Vaginal (metroNIDAZOLE topical)." Oceanside Pharmaceuticals, Bridgewater, NJ. </p><p id="ref_9">9. "Product Information. Noritate (metroNIDAZOLE topical)." sanofi-aventis, Bridgewater, NJ. </p><h2>More about metronidazole topical</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>269 Reviews</li>
<li>Drug class: topical anti-rosacea agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Metronidazole vaginal</li>
<li>Metronidazole Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Metronidazole Vaginal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +5 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Rosacea</li>
<li>Bacterial Vaginitis</li>
<li>Perioral Dermatitis</li>
<li>Balanoposthitis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>